Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 62531 · Class II, Class III · Central Blood Bank
Key facts
| Event ID | 62531 |
|---|---|
| Recall numbers | B-2467-12, B-2468-12, B-2469-12, B-2470-12, B-2471-12 |
| Recalling firm | Central Blood Bank |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing, Fresh Frozen Plasma, Platelets, Red Blood Cells, Red Blood Cells (Apheresis) |
| Classification | Class II, Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed. |
| Initiation date | May 25, 2012 |
| Report date | Sep 5, 2012 |
| Termination date | Aug 24, 2012 |
| City | Pittsburgh |
| State | PA |
| Country | United States |
| FEI number | 2571073 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: